Increase In The Prevalence Of Blood Disorders Boost The Market For Hemostasis Products Driving Market Acceleration in the Hemostasis Products Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts

How Large Will the Hemostasis Products Market Size By 2025?
Over the past few years, there has been significant growth in the size of the hemostasis products market. The forecast suggests that this market will expand from $1.7 billion in 2024 to $1.81 billion in 2025, representing a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth during the historical period include an increase in surgical procedures, a growing elderly population, a rising incidence of hemophilia, an expanding healthcare infrastructure, and heightened awareness of blood clotting disorders.

How Big Is the Hemostasis Products Market Size Expected to Grow by 2029?
Anticipations of robust expansion are prevalent for the hemostasis products market in the following years. It is projected to escalate to $2.31 billion by 2029 with a compound annual growth rate (CAGR) of 6.3%. The market's development through the forecast period can be ascribed to surging demands for minimally invasive surgeries, a worldwide increase in trauma incidents, the wide-ranging application of hemostasis in chronic disease management, transition towards ambulatory surgical centers, personal medicine, and biomarker study. Key trends for the forecast period encompass technological breakthroughs in hemostasis, enhancements in hemostatic solutions, growing preference for minimally invasive procedures, increasing occurrence of chronic illnesses, and a focus on biodegradable hemostatic agents.

View the full report here:
https://www.thebusinessresearchcompany.com/report/hemostasis-products-global-market-report

Which Key Market Drivers Powering Hemostasis Products Market Expansion and Growth?
The escalation in the occurrence of blood disorders is anticipated to drive the expansion of the hemostasis products market. Blood disorders, also identified as hematologic disorders, are a set of health conditions impacting the structure, functionality, and habits of the blood and its constituents. Hemostasis products are employed in numerous blood disorders to handle the coagulation and bleeding mechanisms within the human body. They can manage excessive bleeding (hemorrhage) and clotting (thrombosis) happening in various blood disorders. For instance, the Leukemia and Lymphoma Society, a US-based organization, reported that in 2022, per 1,00,000 people in the United States diagnosed with Leukemia in 2021 increased from 14.1 to 14.3. Accordingly, the rise in the incidence of blood disorders is fuelling the hemostasis products market's growth. The surge in occurrences of cardiac disorders is also anticipated to fuel the hemostasis products market's expansion. Cardiac disorders encompass a wide range of health conditions affecting the heart and blood vessels. Hemostasis products play a valuable role in managing bleeding associated with these disorders and in their prevention and treatment. They have the potential to limit blood loss, reducing the requirement for blood transfusion and possible complications in cardiac disorders. For instance, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease in January 2024 rose to 233.3 per 100,000, a 4.0% increase from 224.4 per 100,000 in 2023. Therefore, the growing incidence of cardiac disorders is contributing to the growth of the hemostasis products market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13244&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Hemostasis Products Market?
Leading businesses in the hemostasis products market, such as Medtronic PLC, are pioneering the development of innovative medical drugs like the Nexpowder endoscopic hemostasis system. They are seeking approval for a comprehensive assortment of active and passive hemostatic drugs for controlling blood losses. The endoscopic hemostasis system, an advanced medical device and method, is implemented to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. To illustrate, in September 2022, US-based medical equipment company Medtronic PLC attained approval from the U.S. Food and Drug Administration for its Nexpowder Endoscopic Hemostasis System. This system aims to manage nonvariceal upper GI bleeding, and it's designed to work alongside endoscopy. Given its simplicity, effectiveness, and patient tolerance, it carries the potential to majorly influence the treatment of nonvariceal upper GI bleeding.

What Are the Emerging Segments in the Hemostasis Products Market?
The hemostasis products market covered in this report is segmented -

1) By Product: Topical Hemostasis Product, Infusible Hemostasis Product, Advanced Hemostasis Product
2) By Application: Trauma, Surgery, Hemophilia, Myocardial Infarction, Other Applications
3) By End User: Hospitals, Clinics, Other End Users

Subsegments:
1) By Topical Hemostasis Product: Hemostatic Agents, Tissue Sealants, Fibrin Sealants
2) By Infusible Hemostasis Product: Platelet-Rich Plasma (PRP), Coagulation Factors, Prothrombin Complex Concentrates
3) By Advanced Hemostasis Product: Biological Adhesives, Synthetic Hemostatic Agents, Hemostatic Dressings

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13244&type=smp

Who Are the Global Leaders in the Hemostasis Products Market?
Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic PLC, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew PLC, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV

Which are the Top Profitable Regional Markets for the Hemostasis Products Industry?
North America was the largest region in the hemostasis products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13244

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.